| |
| |
|
| Insider
Information: |
Staab Thomas R Ii |
| Relationship: |
Chief Financial Officer |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
266,963 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,003,164 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
266,963 |
|
|
| Total
Value |
$1,003,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 5.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Senior Vice President ... |
2019-05-17 |
125,176 |
2011-07-01 |
0 |
Premium* |
|
|
Lensar, Inc. |
LNSR |
Chief Financial Officer |
2023-01-11 |
141,787 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,656 |
141,787 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2022-12-07 |
4 |
B |
$3.16 |
$2,294 |
D/D |
727 |
135,131 |
2.66 |
% |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2022-12-06 |
4 |
B |
$3.16 |
$6,403 |
D/D |
2,025 |
134,404 |
2.74 |
% |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
131,409 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial Officer |
• – – |
2020-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,276 |
115,657 |
0 |
- |
|
| LNSR |
Lensar, Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
96,381 |
|
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-17 |
4 |
AS |
$7.45 |
$18,625 |
D/D |
(2,500) |
125,176 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-16 |
4 |
AS |
$7.72 |
$55,970 |
D/D |
(7,250) |
127,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-16 |
4 |
OE |
$1.42 |
$6,745 |
D/D |
4,750 |
134,926 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-15 |
4 |
AS |
$7.92 |
$57,420 |
D/D |
(7,250) |
130,176 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-15 |
4 |
OE |
$1.42 |
$6,745 |
D/D |
4,750 |
137,426 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-14 |
4 |
OE |
$1.42 |
$6,390 |
D/D |
4,500 |
137,176 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-14 |
4 |
AS |
$7.62 |
$34,290 |
D/D |
(4,500) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-13 |
4 |
OE |
$5.51 |
$53,723 |
D/D |
9,750 |
142,426 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-13 |
4 |
AS |
$7.76 |
$75,660 |
D/D |
(9,750) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-09 |
4 |
OE |
$5.51 |
$53,723 |
D/D |
9,750 |
142,426 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-09 |
4 |
AS |
$7.63 |
$74,393 |
D/D |
(9,750) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-06 |
4 |
AS |
$7.75 |
$69,750 |
D/D |
(9,000) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-06 |
4 |
OE |
$5.51 |
$49,590 |
D/D |
9,000 |
141,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-02 |
4 |
AS |
$7.30 |
$56,575 |
D/D |
(7,750) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-05-02 |
4 |
OE |
$5.51 |
$42,703 |
D/D |
7,750 |
140,426 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-04-04 |
4 |
AS |
$8.81 |
$66,075 |
D/D |
(7,500) |
132,676 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-04-04 |
4 |
OE |
$5.51 |
$41,325 |
D/D |
7,500 |
140,176 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-01-28 |
4 |
AS |
$9.85 |
$49,250 |
D/D |
(5,000) |
128,426 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior Vice President and CFO |
• • – |
2019-01-28 |
4 |
OE |
$5.45 |
$27,250 |
D/D |
5,000 |
133,426 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
